Latest Headlines

Latest Headlines

ConforMIS withdraws FDA submission for iTotal Hip, to resubmit in second half

Personalized 3-D printed joint implants may seem like a no-brainer. But troubled small-cap ConforMIS has struggled to dig in its heels since a $135 million IPO last June. Last fall, the implant maker faced a recall due to packaging problems. And now the FDA has forced its hand on a regulatory submission for a hip implant--causing it to withdraw the application in the face of unanticipated questions.

On a recall, 3-D printed knee implant maker ConforMIS falls 25% to IPO price

ConforMIS had one of the most staggeringly successful med tech IPOs this summer. Its July IPO raised more than $155 million at a $15 share price. The custom 3-D printed orthopedic implant company saw its share price climb as high as almost $27--but all that ground has been lost on this week's news of a voluntary recall by the company.

The massive med tech IPO: ConforMIS, Glaukos and Natera aim for $100M+

Custom knee implant maker ConforMIS has priced the latest major med tech IPO with its $135 million offering on July 1. Investor appetite for large med tech IPOs raising more than $100 million remains whetted, despite the encroachment of the summer doldrums that can slow Wall Street activity to a crawl.

Med techs gather IPO momentum: ConforMIS files for up to $173M, EndoChoice gets set as AirXpander starts in Australia

Med techs are looking to revive public market interest. Several IPOs priced during the first few months of the year--but there's been a lull lately. Custom joint replacement maker ConforMIS is readying an IPO to raise up to $172.5 million, while gastrointestinal endoscopy player EndoChoice has set terms to raise $100 million. Also, Palo Alto, CA-based, breast tissue expansion company AirXpander is starting an IPO to raise A$36.5 million (US $28.3 million) on the Australian Securities Exchange.

ConforMIS plots new moves after pumping up venture round to $168M

Orthopedic implant maker ConforMIS disclosed that it has expanded--and come close to doubling--its Series E financing to a whopping $167.7 million.

Top 10 VC Device deals of H1 2012

  These are dubious times for medical device companies seeking venture investment.  

Orthopedic implant maker ConforMIS blessed with $73M in new funding

ConforMIS successfully raised $73 million through the sale of stock and convertible securities on Wednesday. The fundraising, noted in a new regulatory filing, is a bit of a coup, in fact, surpassing an initially-announced plan to pull in $68 million through the action.

ConforMIS, an orthopedics implant maker, to raise $68M

ConforMIS, which makes orthopedics implants, plans to raise $68 million in an equity and securities funding round, according to a recent regulatory filing.

ConforMis nails $89M for iTotal knee manufacturing + launch

ConforMIS will use $89 million in newly raised investor financing to fuel the commercial launch and manufacturing of its new iTotal total knee replacement system. The Burlington, MA-based company

ConforMIS secures $1.4M loan from tech fund

ConforMIS has secured a $1.4 million loan from MassDevelopment's Emerging Technology Fund. The loan will go toward growing the Burlington, MA-based company's supply chain and manufacturing capacity